Search - tctmd.com

Displaying 1 - 20 of 35

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

News Daily News

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

L.A. McKeown

October 17, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

Small Study Hints at Mechanism for COVID-Related MI and Stroke

L.A. McKeown

October 02, 2023

News Daily News

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Michael O'Riordan

July 28, 2023

News CV Team Pro

Viet Le

L.A. McKeown

July 07, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Diabetes Progression in Statin-Treated Patients: VA Data

Michael O'Riordan

October 06, 2021

News Daily News

As CDC Moves to Update Contraception Guidance, Cardiologists Should Take Note

Alexandra Dangas

September 06, 2021

News Conference News ACC 2021

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Caitlin E. Cox

May 07, 2021

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Features

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

Shelley Wood

April 21, 2020

News Daily News

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

Yael L. Maxwell

February 12, 2020

COLCOT Renews Hope for Anti-inflammatory Secondary Prevention

News Conference News AHA 2019

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Caitlin E. Cox

November 16, 2019

News Daily News

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Yael L. Maxwell

October 22, 2019

News Daily News

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Michael O'Riordan

July 19, 2019

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2025

Prenatal Hyperlipidemia: ‘Canary in a Coal Mine’ for Maternal Health?

September 2025 Dispatch for the CV Team

June 2025 Dispatch for the CV Team

March 2024 Dispatch for the CV Team

Small Study Hints at Mechanism for COVID-Related MI and Stroke

New AHA/ACC Performance and Quality Metrics for Coronary Revascularization

Viet Le

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Diabetes Progression in Statin-Treated Patients: VA Data

As CDC Moves to Update Contraception Guidance, Cardiologists Should Take Note

Social Determinants of Health Tied to Fewer COVID-19 Precautions in CVD Patients

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Obesity and COVID-19: Theories and Blame Fill the Scientific Void

Long-term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment

COLCOT Renews Hope for Anti-inflammatory in Secondary Prevention: Colchicine

Evolocumab Safe and Effective Out to 5 Years: OSLER-1

Intensive Lipid-Lowering Slashes CVD in Elderly ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content